Related Experiment Video
Updated: Oct 17, 2026
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Co-expression of vascular endothelial growth factor and its receptor flt-1 in malignant pleural mesothelioma
J König1, E Tolnay, T Wiethege
1Institute of Pathology, and German Mesothelioma Registry, University Hospital Bergmannsheil, Ruhr University Bochum, Germany.
Background:
Vascular endothelial growth factor (VEGF) is a potent angiogenic protein with a selective mitogenic effect on endothelial cells known to be involved in many normal and pathological processes. Coexpression of VEGF and its receptor flt-1 has been reported in different types of malignant tumors.
Objective:
In the present study we investigated the expression of VEGF and flt-1 in 90 cases of diffuse malignant pleural mesotheliomas.
Methods:
VEGF and flt-1 expression was analyzed by immunohistochemistry and non-radioactive in situ hybridization.
Results:
VEGF expression was visualized immunohistochemically in tumor cells. flt-1 expression correlated with histological differentiation (p < 0.013). Furthermore, expression of flt-1 was detected in tumor cells, macrophages and microvessels adjacent to tumor cells. VEGF and flt-1 expression were confirmed by in situ hybridization.
Conclusion:
There was a statistically significant correlation between VEGF and flt-1 expression (p < 0.001). The observed coexpression of VEGF and flt-1 possibly suggests a potential autocrine loop for malignant pleural mesothelioma cells.
Related Concept Videos
02:38Mitogens and the Cell Cycle
02:17The Tumor Microenvironment
01:24Regulation of Angiogenesis and Blood Supply
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...